Terrell A. Patterson

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Jeffrey H. Schwartz, Balarama Gundapaneni, Perry Elliott et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

D₂Receptors May Modulate the Function of the Striatal Transporter for Dopamine: Kinetic Evidence from Studies In Vitro and In Vivo

Susan M. Meiergerd, Terrell A. Patterson, James O. Schenk · Journal of Neurochemistry · 1993 · 227 citations

Life Sciences, Neuroscience, Pharmacology +16

Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study

Thibaud Damy, Pablo García‐Pavía, Mazen Hanna et al. · European Journal of Heart Failure · 2020 · 208 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Food Deprivation Decreases mRNA and Activity of the Rat Dopamine Transporter

Terrell A. Patterson, Michelle D. Brot, Aryana Zavosh et al. · Neuroendocrinology · 1998 · 152 citations

Life Sciences, Neurobiology, Neuroscience +17

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy et al. · Neuropharmacology · 2006 · 132 citations

Medicine, Medicinal Chemistry, Pharmacology +11